Ruxolitinib withdrawal due to the COVID-19

被引：4
|
作者：
Lucijanic, Marko [1 ,2 ]
Kusec, Rajko [1 ,2 ,3 ]
机构：
[1] Univ Hosp Dubrava, Hematol Dept, Zagreb, Croatia
[2] Univ Zagreb, Sch Med, Zagreb, Croatia
[3] Univ Hosp Dubrava, Div Mol Diag & Genet, Clin Dept Lab Diagnost, Zagreb, Croatia
来源：
LEUKEMIA | 2021年 / 35卷 / 04期
关键词：
D O I：
10.1038/s41375-021-01214-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1218 / 1218
页数：1
相关论文
共 50 条
  • [1] Ruxolitinib withdrawal due to the COVID-19
    Marko Lucijanic
    Rajko Kusec
    [J]. Leukemia, 2021, 35 : 1218 - 1218
  • [2] Response to: Ruxolitinib withdrawal due to the COVID-19
    Tiziano Barbui
    Alessandra Carobbio
    [J]. Leukemia, 2021, 35 : 1219 - 1219
  • [3] Response to: Ruxolitinib withdrawal due to the COVID-19
    Barbui, Tiziano
    Carobbio, Alessandra
    [J]. LEUKEMIA, 2021, 35 (04) : 1219 - 1219
  • [4] Ruxolitinib and Severe COVID-19
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    [J]. INFECTION AND CHEMOTHERAPY, 2021, 53 (04): : 796 - 796
  • [5] High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
    Tiziano Barbui
    Alessandro Maria Vannucchi
    Alberto Alvarez-Larran
    Alessandra Iurlo
    Arianna Masciulli
    Alessandra Carobbio
    Arianna Ghirardi
    Alberto Ferrari
    Giuseppe Rossi
    Elena Elli
    Marcio Miguel Andrade-Campos
    Mercedes Gasior Kabat
    Jean-Jaques Kiladjian
    Francesca Palandri
    Giulia Benevolo
    Valentin Garcia-Gutierrez
    Maria Laura Fox
    Maria Angeles Foncillas
    Carmen Montoya Morcillo
    Elisa Rumi
    Santiago Osorio
    Petros Papadopoulos
    Massimiliano Bonifacio
    Keina Susana Quiroz Cervantes
    Miguel Sagues Serrano
    Gonzalo Carreno-Tarragona
    Marta Anna Sobas
    Francesca Lunghi
    Andrea Patriarca
    Begona Navas Elorza
    Anna Angona
    Elena Magro Mazo
    Steffen Koschmieder
    Marco Ruggeri
    Beatriz Cuevas
    Juan Carlos Hernandez-Boluda
    Emma Lopez Abadia
    Blanca Xicoy Cirici
    Paola Guglielmelli
    Marta Garrote
    Daniele Cattaneo
    Rosa Daffini
    Fabrizio Cavalca
    Beatriz Bellosillo
    Lina Benajiba
    Natalia Curto-Garcia
    Marta Bellini
    Silvia Betti
    Valerio De Stefano
    Claire Harrison
    [J]. Leukemia, 2021, 35 : 485 - 493
  • [6] High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
    Barbui, Tiziano
    Vannucchi, Alessandro Maria
    Alvarez-Larran, Alberto
    Iurlo, Alessandra
    Masciulli, Arianna
    Carobbio, Alessandra
    Ghirardi, Arianna
    Ferrari, Alberto
    Rossi, Giuseppe
    Elli, Elena
    Andrade-Campos, Marcio Miguel
    Kabat, Mercedes Gasior
    Kiladjian, Jean-Jaques
    Palandri, Francesca
    Benevolo, Giulia
    Garcia-Gutierrez, Valentin
    Fox, Maria Laura
    Foncillas, Maria Angeles
    Morcillo, Carmen Montoya
    Rumi, Elisa
    Osorio, Santiago
    Papadopoulos, Petros
    Bonifacio, Massimiliano
    Cervantes, Keina Susana Quiroz
    Serrano, Miguel Sagues
    Carreno-Tarragona, Gonzalo
    Sobas, Marta Anna
    Lunghi, Francesca
    Patriarca, Andrea
    Elorza, Begona Navas
    Angona, Anna
    Mazo, Elena Magro
    Koschmieder, Steffen
    Ruggeri, Marco
    Cuevas, Beatriz
    Hernandez-Boluda, Juan Carlos
    Abadia, Emma Lopez
    Cirici, Blanca Xicoy
    Guglielmelli, Paola
    Garrote, Marta
    Cattaneo, Daniele
    Daffini, Rosa
    Cavalca, Fabrizio
    Bellosillo, Beatriz
    Benajiba, Lina
    Curto-Garcia, Natalia
    Bellini, Marta
    Betti, Silvia
    De Stefano, Valerio
    Harrison, Claire
    [J]. LEUKEMIA, 2021, 35 (02) : 485 - 493
  • [7] IMPACT OF ILOPROST WITHDRAWAL IN SCLERODERMA PATIENTS DUE TO COVID-19 PANDEMIC
    Verardi, L.
    De Lorenzis, E.
    Natalello, G.
    Gigante, L.
    Cerasuolo, P. G.
    D'Agostino, M. A.
    Bosello, S. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1476 - 1477
  • [8] Ruxolitinib in COVID-19 Hyperinflammation and Haematologic Malignancies
    La Rosee, Felicitas
    La Rosee, Paul
    [J]. ACTA HAEMATOLOGICA, 2021, 144 (03) : 246 - 248
  • [9] COVID-19 in a patient with SISTEMIC sclerosis: The role of ruxolitinib
    Ucciferri, Claudio
    Auricchio, Antonio
    Marinari, Stefano
    Vecchiet, Jacopo
    Falasca, Katia
    [J]. EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [10] Myositis due to COVID-19
    Uslu, Sadettin
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1148) : 399 - 399
12345